Top MenuAbout
Top MenuTherapy Areas
- Therapy Areas
  Urology
  Oncology / Haematology
  Transplantation
  Women’s Health
- Astellas Products
  BETMIGA™ (mirabegron)
  XTANDI™ (enzalutamide)
  XOSPATA™ (gilteritinib)
  ADVAGRAF™ (tacrolimus prolonged release)
  PROGRAF™ (tacrolimus)
  PADCEV™ (enfortumab vedotin)
  VEOZA™ (fezolinetant)
Top MenuInnovation
Clinical Trials
Astellas has established a website to disclose information obtained from Astellas-sponsored clinical trials…
לקריאה נוספת
Top MenuSustainability
Access to Health
Advances continue to be made in technology and medicine that address unmet medical needs. However, there still remain barriers for many people…
לקריאה נוספת
Top MenuNews
Media Contacts
The Astellas Corporate Communications team will respond to calls and emails from journalists. For general media enquiries, please email contact_uk...
לקריאה נוספת

Common header menu

CONTACT US
CAREERS
WORLDWIDE
ISRAEL
WORLDWIDE - ISRAEL

English
עברית

Home
Leaving Astellas Pharma IL

You are now leaving www.astellas.com/il

You are about to leave the www.astellas.com/il environment and be redirected to:

Follow us on social media

Bottom footer menu

SITE MAP
PRIVACY NOTICE
TERMS OF USE
COOKIES POLICY

© 2024 Astellas Pharma Inc.

Update cookie preference